Literature DB >> 7722586

Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research.

Y Moride1, L Abenhaim, M Yola, A Lucein.   

Abstract

Past experience with a drug may modify the risk of adverse event associated with current use of this drug. This effect was investigated empirically with a study on non-steroidal anti-inflammatory drugs (NSAIDs)-gastropathy. A hospital-based case-control study was conducted with 244 cases of upper gastrointestinal bleeding (UGIB) age 68 and over and 615 matched controls. Data on all medications dispensed to the study patients during the 3 years preceding admission were obtained from the Quebec universal prescription program automated database. Recent use (within 30 days prior to admission) of non-aspirin NSAIDs increased the risk of UGIB. The estimate of relative risk (RR) was 3.4 (CI, 2.1-5.5). Use of NSAIDs in the previous 3 years was associated with a lower risk of UGIB; the estimate of RR was 0.7 (CI, 0.4-1.0). The estimate of RR for first-time users was 22.7 (2.8-200.0) vs 3.0 (1.9-4.7) for those who had used the drugs at least once in the past 3 years. These results provide empirical evidence of a depletion of susceptibles effect whereby patients who remain on the drugs are those who can tolerate them while those who are susceptible select themselves out of the population at risk. Thus, past use should be considered as a potential risk modifier in non-experimental risk assessment of events associated with drug use.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7722586     DOI: 10.1016/0895-4356(94)90170-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  73 in total

Review 1.  Design issues for drug epidemiology.

Authors:  A D McMahon; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

2.  Modified prescription-event monitoring studies: a tool for pharmacovigilance and risk management.

Authors:  Deborah Layton; Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

3.  Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers.

Authors:  Marie Tournier; Bernard Bégaud; Audrey Cougnard; Guy-Robert Auleley; Jean Deligne; Claudine Blum-Boisgard; Anne C M Thiébaut; Hélène Verdoux
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

4.  Vulnerable Patients and Potential Harms: The Contribution of Observational Research.

Authors:  Deborah Layton
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

5.  Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.

Authors:  Sylvie Perreault; Lucie Blais; Alice Dragomir; Marie-Hèlène Bouchard; Lyne Lalonde; Claudine Laurier; Johanne Collin
Journal:  Eur J Clin Pharmacol       Date:  2005-10-19       Impact factor: 2.953

6.  Comparative gastrointestinal safety of weekly oral bisphosphonates.

Authors:  S M Cadarette; J N Katz; M A Brookhart; T Stürmer; M R Stedman; R Levin; D H Solomon
Journal:  Osteoporos Int       Date:  2009-03-06       Impact factor: 4.507

7.  Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study.

Authors:  Lamiae Grimaldi-Bensouda; Lucien Abenhaim; Laurent Michaud; Olivier Mouterde; Annie Pierre Jonville-Béra; Bruno Giraudeau; Benoît David; Elisabeth Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2010-05-16       Impact factor: 2.953

8.  Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies.

Authors:  Shoroq M Altawalbeh; Carolyn T Thorpe; Janice C Zgibor; Sandra Kane-Gill; Yihuang Kang; Joshua M Thorpe
Journal:  J Am Geriatr Soc       Date:  2016-06-28       Impact factor: 5.562

9.  An introduction to the fundamentals of cohort and case-control studies.

Authors:  John-Michael Gamble
Journal:  Can J Hosp Pharm       Date:  2014-09

10.  The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Authors:  Jennifer L Lund; David B Richardson; Til Stürmer
Journal:  Curr Epidemiol Rep       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.